These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21186192)

  • 1. Comment on: A potential role for daptomycin in enterococcal infections: what is the evidence?
    Cai T; Mazzoli S; Malossini G; Bartoletti R
    J Antimicrob Chemother; 2011 May; 66(5):1195-6; author reply 1196-7. PubMed ID: 21186192
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections.
    Fisher L; North D
    Int J Antimicrob Agents; 2009 May; 33(5):493-4. PubMed ID: 19153034
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
    Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
    Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin.
    Prescrire Int; 2007 Dec; 16(92):245. PubMed ID: 18095389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is combination systemic therapy superior to monotherapy for enterococcal prosthetic joint infection?
    Nsutebu EF; Hobson R
    Clin Infect Dis; 2009 Feb; 48(4):495; author reply 495-6. PubMed ID: 19586378
    [No Abstract]   [Full Text] [Related]  

  • 6. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave V; Garcia-Diaz J; Islam T; Hasbun R
    J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with daptomycin: bacteraemia and endocarditis.
    Levine DP
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii35-39. PubMed ID: 18829724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: safety and efficacy of high-dose and prolonged therapy.
    Yuste JR; Quesada M; Díaz-Rada P; Del Pozo JL
    Int J Infect Dis; 2014 Oct; 27():65-6. PubMed ID: 25192907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia.
    Avery LM; Kuti JL; Weisser M; Egli A; Rybak MJ; Zasowski EJ; Arias CA; Contreras GA; Chong PP; Aitken SL; DiPippo AJ; Wang JT; Britt NS; Nicolau DP
    Int J Antimicrob Agents; 2019 Sep; 54(3):346-350. PubMed ID: 31284042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical enterococcal coverage for complicated intra-abdominal infection.
    Tarchini G
    Clin Infect Dis; 2010 Sep; 51(6):757-8; author reply 758-9. PubMed ID: 20731571
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin.
    Deville JG; Goldfarb J; Kaplan SL; Equils O; Huang DB; Ang JY; Salazar JC
    J Antimicrob Chemother; 2010 Oct; 65(10):2267-70. PubMed ID: 20705627
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.
    Huen SC; Hall I; Topal J; Mahnensmith RL; Brewster UC; Abu-Alfa AK
    Am J Kidney Dis; 2009 Sep; 54(3):538-41. PubMed ID: 19237231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in treatment of antimicrobial-resistant enterococcal infections.
    Xia L; Murray BE
    Curr Clin Top Infect Dis; 2000; 20():92-112. PubMed ID: 10943520
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
    Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
    Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
    [No Abstract]   [Full Text] [Related]  

  • 20. Daptomycin use in a neonate: serum level monitoring and outcome.
    Sarafidis K; Iosifidis E; Gikas E; Tsivitanidou M; Drossou-Agakidou V; Roilides E
    Am J Perinatol; 2010 May; 27(5):421-4. PubMed ID: 20013573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.